Interestingly, individuals with a five‐fold higher concentration of GFAP at baseline displayed accelerated hippocampal atrophy and decreases in cortical thickness over the up to 16‐year follow‐up period, suggesting that elevations in GFAP may predict future risk of neurodegeneration. Here, GFAP is linked to hippocampal atrophy.